期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
^(125)I粒子植入治疗盆腔及后腹膜肿瘤23例分析 被引量:8
1
作者 娄成 钱建新 +1 位作者 顾小强 武清 《介入放射学杂志》 CSCD 北大核心 2016年第7期631-634,共4页
目的评价CT引导下放射性^(125)I粒子植入治疗盆腔及后腹膜恶性肿瘤的临床疗效。方法 23例盆腔及后腹膜恶性肿瘤患者,在CT引导下行放射性^(125)I粒子植入。粒子植入前1周行腹部或盆腔螺旋CT扫描,将图像传送到计算机三维肿瘤治疗计划系统... 目的评价CT引导下放射性^(125)I粒子植入治疗盆腔及后腹膜恶性肿瘤的临床疗效。方法 23例盆腔及后腹膜恶性肿瘤患者,在CT引导下行放射性^(125)I粒子植入。粒子植入前1周行腹部或盆腔螺旋CT扫描,将图像传送到计算机三维肿瘤治疗计划系统;勾画靶区轮廓(同时勾画肿瘤周围危险器官,如膀胱、肠管、大血管等);靶区及相关轮廓三维重建;确定肿瘤靶区放射剂量、粒子数量和粒子空间排列。术后随访均设定4个月,以观察局部治疗效果、有无消化道或泌尿系等不良反应、疼痛变化情况、局部肿瘤缓解情况。结果本组23例中有16例患者术前有骶尾部或腰背部疼痛,术后5~14 d疼痛缓解,缓解率为69.6%,局部疼痛缓解近期疗效较显著。肿瘤局部控制2个月时有效率(CR+PR)为47.8%(11/23);4个月时有效率为43.5%(10/23)。患者术后随访未见腹痛、肠瘘、出血、尿痛等不良反应,也未见放射性肠炎、骨髓抑制等并发症。结论初步研究表明CT引导下经皮穿刺植入^(125)I粒子近距离内照射治疗盆腔及后腹膜肿瘤安全、局部疗效明显等优势。对于无法手术、术后复发及单纯化、放疗效果差的盆腔及后腹膜恶性肿瘤是一种有效的补救治疗措施,并有效改善患者生存质量、提高肿瘤局部控制率。 展开更多
关键词 ^125I粒子 后腹盆及腔膜恶性肿瘤 CT引导下 临床疗效
下载PDF
腹膜后脂肪肉瘤诊断和治疗专家共识(2016) 被引量:56
2
作者 罗成华 金黑鹰 +2 位作者 苗成利 杨邵敏 冯元春 《中国微创外科杂志》 CSCD 北大核心 2016年第12期1057-1063,共7页
1概述 腹膜后解剖位置是位于横膈以下和盆膈以上,后壁层腹膜与腹横筋膜间的潜在腔隙,是腹膜后脂肪肉瘤的好发部位之一。原发性腹膜后脂肪肉瘤是指源于腹膜后脂肪组织的非特定脏器的一类肿瘤。腹膜后脂肪肉瘤是最常见的腹膜后肿瘤,约占... 1概述 腹膜后解剖位置是位于横膈以下和盆膈以上,后壁层腹膜与腹横筋膜间的潜在腔隙,是腹膜后脂肪肉瘤的好发部位之一。原发性腹膜后脂肪肉瘤是指源于腹膜后脂肪组织的非特定脏器的一类肿瘤。腹膜后脂肪肉瘤是最常见的腹膜后肿瘤,约占原发性腹膜后软组织肉瘤的45%。 展开更多
关键词 后脂肪 肿瘤 后解剖 壁层 专家共识 潜在 横筋 输尿管支 横膈
下载PDF
Sentinel Lymph Node Identification in Endometrial Cancer
3
作者 Bin Li Lingying Wu +5 位作者 Xiaoguang Li wHaizhen Lu Ping Bai Shumin Li Wenhua Zhang Jǖzhen Gao 《Chinese Journal of Clinical Oncology》 CSCD 2009年第2期124-128,共5页
OBJECTIVE To evaluate the feasibility of intra-operativedetection of sentinel lymph nodes (SLN) in the patient withendometrial cancer (EC).METHODS Thirty-one patients with Stage Ⅰ and Ⅱ endometrialcancer, who underw... OBJECTIVE To evaluate the feasibility of intra-operativedetection of sentinel lymph nodes (SLN) in the patient withendometrial cancer (EC).METHODS Thirty-one patients with Stage Ⅰ and Ⅱ endometrialcancer, who underwent a hysterectomy and a lymphadenectomy,were enrolled in the study. At laparotomy, methylene blue dyetracer was injected into the subserosal myometrium of corpusuteri at multiple sites, and dye uptake into the lymphatic channelswas observed. The blue nodes which were identified as SLNs weretraced and excised. The other nodes were then removed. All of theexcised nodes were submitted for pathological hematoxylin andeosin (H&E) staining examination.RESULTS Failure of dye uptake occurred in 4 of the 31 cases(12.9%) because of spillage, and no lymphatic coloration wasobserved there. Lymphatic staining was clearly observable as bluedye diffused to the lymphatic channels of the uterine surface andthe infundibulopelvic ligaments in 27 (87.1%) cases. Concurrentcoloration in the pelvic lymphatic vessels was also observed in 22of the 27 patients. The SLNs were identified in 23 of the 27 (85.2%)cases with a lymphatic staining, with a total number of 90 SLNs,and a mean of 3.9 in each case (range, 1-10). Besides one SLN (1.1%)in the para-aortic area, the other 89 (98.9%) were in the nodes ofthe pelvis. The most dense locations of SLNs included obturator in38 (42.2%) and interiliac in 19 (21.1%) cases. In our group, pelviclymphadenectomy was conducted in 27 (87.1%) patients andpelvic nodal sampling in 4 (12.9%). Of the 31 cases, a concurrentabdominal para-aortic lymph node sampling was conducted in7. A total of 926 nodes were harvested, with an average of 39.8 ineach case (range, 14-55). Nodal metastases occurred in 3 patients(9.7%), 2 of them with SLN involvement and the other withoutSLN involvement. Adverse reactions or injury related to the studywas not found.CONCLUSION Application of methylene blue dye is feasible inan intra-operative SLN identification of endometrial cancer. Thetechnology is convenient, safe, and worth further investigation. 展开更多
关键词 endometrial tumor lymphatic metastasis sentinel lymph node biopsy lymphadenectomy.
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部